Physician
Central Florida Cancer & Blood Center PA
Central Florida Cancer & Blood Center PA was paid $1.07M by Medicaid between Jan 2018 and Nov 2024, across 18 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 44% of everything it billed.
33Billing provider infoCENTRAL FLORIDA CANCER & BLOOD CENTER PA
OCALA, FL 34471
OCALA, FL 34471
33aNPI1124300983assigned 09/16/2011
33bProvider typeHematology & Oncology Physician
28Total paid$1.07M
24GClaims49,210
24DCodes billed18
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Hematology & Oncology Physician providers in Florida
Rank by total paid#5 of 65
Median peer was paid$27K
This provider vs. median40×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 1,004 | $2K | |
| 2019 | 5,008 | $153K | |
| 2020 | 8,686 | $237K | |
| 2021 | 9,887 | $240K | |
| 2022 | 10,856 | $157K | |
| 2023 | 9,462 | $200K | |
| 2024incomplete | 4,307 | $85K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 44% | 8,410 | 5,938 | $474K |
| J1750 | Injection, iron dextran, 50 mg | 12% | 2,892 | 1,339 | $132K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 12% | 4,747 | 2,160 | $130K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 7.0% | 944 | 793 | $75K |
| 99232 | Hospital visit by a doctor, follow-up daySubsequent hospital care, per day, moderate complexity | 6.0% | 3,585 | 574 | $64K |
| Q0138 | Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | 4.6% | 150 | 96 | $49K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 3.9% | 933 | 758 | $42K |
| 96375 | Therapeutic injection; each additional sequential IV push | 3.2% | 5,013 | 2,207 | $35K |
| 99222 | Initial hospital care, per day, moderate complexity | 3.1% | 579 | 464 | $33K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.3% | 7,799 | 5,978 | $13K |
| 99233 | Hospital visit by a doctor, follow-up day (complex)Prolong inpt eval add15 m | <1% | 206 | 158 | $9K |
| J2916 | Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg | <1% | 569 | 228 | $7K |
6 more codes
| J1756 | Injection, iron sucrose, 1 mg | <1% | 163 | $4K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 4,882 | $3K |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 4,088 | $2K |
| 36415 | Collection of venous blood by venipuncture | <1% | 4,146 | $1K |
| J1626 | Injection, granisetron hydrochloride, 100 mcg | <1% | 25 | $16.31 |
| J2780 | Injection, ranitidine hydrochloride, 25 mg | <1% | 79 | $14.40 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialKOTI, RAVI (OWNER)